MGX · Categories · Form 4

MGX - SEC Form 4 insider transactions

Metagenomi Therapeutics Inc. (MGX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MGX

• 33d
  SEC Form 4 filed by Irish Jian

  4 - Metagenomi Therapeutics, Inc. (0001785279) (Issuer)
• 33d
  SEC Form 4 filed by Wein Matthew

  4 - Metagenomi Therapeutics, Inc. (0001785279) (Issuer)
• 33d
  SEC Form 4 filed by Wapnick Pamela

  4 - Metagenomi Therapeutics, Inc. (0001785279) (Issuer)
• 58d
  Chief Financial Officer Wapnick Pamela sold $2,530 worth of shares (1,581 units at $1.60), decreasing direct ownership by 0.84% to 187,375 units (SEC Form 4)

  4 - Metagenomi Therapeutics, Inc. (0001785279) (Issuer)
• 58d
  Officer Wein Matthew sold $771 worth of shares (482 units at $1.60), decreasing direct ownership by 0.42% to 114,549 units (SEC Form 4)

  4 - Metagenomi Therapeutics, Inc. (0001785279) (Issuer)
• 58d
  Chief Executive Officer Irish Jian gifted 228,462 shares and sold $2,571 worth of shares (1,607 units at $1.60), decreasing direct ownership by 41% to 333,770 units (SEC Form 4)

  4 - Metagenomi Therapeutics, Inc. (0001785279) (Issuer)
• 149d
  Director Thomas Brian C. sold $6,786 worth of shares (3,830 units at $1.77), decreasing direct ownership by 0.15% to 2,510,960 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 149d
  Officer Wein Matthew sold $353 worth of shares (199 units at $1.77), decreasing direct ownership by 0.17% to 115,031 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 149d
  Chief Financial Officer Wapnick Pamela sold $2,793 worth of shares (1,576 units at $1.77), decreasing direct ownership by 0.83% to 188,956 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 149d
  Chief Executive Officer Irish Jian sold $2,839 worth of shares (1,602 units at $1.77), decreasing direct ownership by 0.28% to 563,839 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 156d
  Director Thomas Brian C. sold $4,889 worth of shares (2,701 units at $1.81), decreasing direct ownership by 0.11% to 2,514,790 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 156d
  Chief Financial Officer Wapnick Pamela sold $2,853 worth of shares (1,576 units at $1.81) and was granted 120,000 shares, increasing direct ownership by 164% to 190,532 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 156d
  Chief Executive Officer Irish Jian sold $2,900 worth of shares (1,602 units at $1.81) and was granted 248,500 shares, increasing direct ownership by 78% to 565,441 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 156d
  Officer Wein Matthew sold $360 worth of shares (199 units at $1.81) and was granted 96,000 shares, increasing direct ownership by 493% to 115,230 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 246d
  SEC Form 4 filed by Director Reid Laurence

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 328d
  SEC Form 4 filed by Director Eckhardt Juergen

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 328d
  SEC Form 4 filed by Director Dere Willard H

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 328d
  SEC Form 4 filed by Director Bjerkholt Eric

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 331d
  Officer Wein Matthew sold $348 worth of shares (199 units at $1.75), decreasing direct ownership by 1% to 16,693 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 331d
  Chief Medical Officer Noonberg Sarah B. sold $9,168 worth of shares (5,239 units at $1.75), decreasing direct ownership by 5% to 109,135 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 331d
  Chief Financial Officer Wapnick Pamela sold $2,758 worth of shares (1,576 units at $1.75), decreasing direct ownership by 2% to 72,108 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 331d
  Chief Executive Officer Thomas Brian C. sold $18,874 worth of shares (10,785 units at $1.75), decreasing direct ownership by 0.43% to 2,517,491 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 331d
  Officer Irish Jian sold $11,182 worth of shares (6,390 units at $1.75), decreasing direct ownership by 2% to 315,543 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 398d
  Chief Financial Officer Wapnick Pamela was granted 14,000 shares, increasing direct ownership by 23% to 73,684 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 398d
  Chief Executive Officer Thomas Brian C. was granted 32,000 shares, increasing direct ownership by 1% to 2,528,276 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 398d
  Officer Irish Jian was granted 23,000 shares, increasing direct ownership by 8% to 321,933 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 398d
  Officer Wein Matthew was granted 7,425 shares, increasing direct ownership by 78% to 16,892 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 398d
  Chief Medical Officer Noonberg Sarah B. was granted 14,000 shares, increasing direct ownership by 14% to 114,374 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 425d
  Officer Wein Matthew sold $1,744 worth of shares (930 units at $1.87), decreasing direct ownership by 9% to 9,467 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 425d
  Chief Financial Officer Wapnick Pamela sold $3,390 worth of shares (1,808 units at $1.87), decreasing direct ownership by 3% to 59,684 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 455d
  SEC Form 4 filed by Director Bjerkholt Eric

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 516d
  Chief Financial Officer Wapnick Pamela sold $2,900 worth of shares (1,559 units at $1.86), decreasing direct ownership by 2% to 61,492 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 607d
  Chief Financial Officer Wapnick Pamela sold $18,043 worth of shares (6,265 units at $2.88), decreasing direct ownership by 9% to 63,051 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Irish Jian was granted 70,471 shares, increasing direct ownership by 31% to 298,933 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  SEC Form 4 filed by Eckhardt Juergen

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Borges Luis was granted 69,316 shares (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Wein Matthew was granted 10,397 shares (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Wapnick Pamela was granted 69,316 shares (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Noonberg Sarah B. was granted 57,763 shares, increasing direct ownership by 136% to 100,374 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  SEC Form 4 filed by Bernales Sebastian

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Harnest Simon was granted 11,552 shares, increasing direct ownership by 10% to 122,664 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Delaney Simren was granted 6,931 shares, increasing direct ownership by 8% to 93,892 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  SEC Form 4 filed by Dere Willard H

  4 - Metagenomi, Inc. (0001785279) (Issuer)
• 763d
  Thomas Brian C. was granted 118,992 shares, increasing direct ownership by 5% to 2,496,276 units (SEC Form 4)

  4 - Metagenomi, Inc. (0001785279) (Issuer)

Other MGX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends